Ozanimod Hydrochloride

CHEMBL3707246 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

440.9 g/mol

LogP

—

Phase

4

A hydrochloride salt form of ozanimod with the same therapeutic properties. A sphingosine 1-phosphate modulator trapping immune cells for multiple sclerosis and IBD.

Masse moléculaire

440,9000 g/mol

TPSA

104,00 Å²

Aires thérapeutiques

Multiple Sclerosis

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(C)Oc1ccc(-c2nc(-c3cccc4c3CC[C@@H]4NCCO)no2)cc1C#N.Cl

InChI

InChI=1S/C23H24N4O3.ClH/c1-14(2)29-21-9-6-15(12-16(21)13-24)23-26-22(27-30-23)19-5-3-4-18-17(19)7-8-20(18)25-10-11-28;/h3-6,9,12,14,20,25,28H,7-8,10-11H2,1-2H3;1H/t20-;/m0./s1

Molecular Formula

C23H25ClN4O3

HBD / HBA

3 / 7

Liaisons Rotatives

7

Atomes Lourds

31

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A hydrochloride salt form of ozanimod with the same therapeutic properties. A sphingosine 1-phosphate modulator trapping immune cells for multiple sclerosis and IBD.

Yes, Ozanimod Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3707246. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 91618104. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Ozanimod Hydrochloride sur PillFYI

Structure

Données Clés

Formule: C23H25ClN4O3
Synonymes: 1

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.